Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-25 9:00 pm Sale | 2025-11-21 | 13D | Dianthus Therapeutics, Inc. DNTH | Fairmount Funds Management LLC | 2,139,635 4.900% | -1,912,417![]() (-47.20%) | Filing History |
| 2025-11-19 9:15 pm Sale | 2025-11-17 | 13D | Dianthus Therapeutics, Inc. DNTH | Avidity Partners Management LP | 2,104,184 4.900% | -1,274,755![]() (-37.73%) | Filing History |
| 2025-11-14 4:46 pm Purchase | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Octagon Capital Advisors LP | 2,416,667 6.100% | 306,500![]() (+14.52%) | Filing History |
| 2025-11-14 4:30 pm Sale | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | BCLS Fund III Investments, LP | 1,315,892 3.100% | -1,166,358![]() (-46.99%) | Filing History |
| 2025-11-14 4:13 pm Purchase | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | RA CAPITAL MANAGEMENT L.P. | 3,866,733 9.500% | 1,000,000![]() (+34.88%) | Filing History |
| 2025-11-14 4:06 pm Sale | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Vestal Point Capital, LP | 1,180,000 3.000% | -2,020,000![]() (-63.13%) | Filing History |
| 2025-11-14 08:09 am Sale | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Deep Track Capital, LP | 0 0.000% | -2,357,702![]() (Position Closed) | Filing History |
| 2025-11-12 09:33 am Purchase | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | WELLINGTON MANAGEMENT GROUP LLP | 2,577,662 6.500% | 2,577,662![]() (New Position) | Filing History |
| 2025-11-05 11:30 am Purchase | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | FMR LLC | 5,970,638 15.000% | 1,488,029![]() (+33.20%) | Filing History |
| 2025-09-15 4:15 pm Purchase | 2025-09-11 | 13D | Dianthus Therapeutics, Inc. DNTH | Fairmount Funds Management LLC | 4,052,052 9.900% | 1,094,667![]() (+37.01%) | Filing History |
| 2025-09-12 4:10 pm Purchase | 2025-09-11 | 13G | Dianthus Therapeutics, Inc. DNTH | Point72 Asset Management, L.P. | 2,121,140 5.300% | 675,315![]() (+46.71%) | Filing History |
| 2025-08-14 5:58 pm Sale | 2025-06-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Venrock Healthcare Capital Partners III, L.P. | 1,000,000 3.100% | -744,373![]() (-42.67%) | Filing History |
| 2025-08-14 5:33 pm Sale | 2025-06-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Point72 Asset Management, L.P. | 1,445,825 4.500% | -448,479![]() (-23.68%) | Filing History |
| 2025-08-14 4:00 pm Sale | 2025-06-30 | 13G | Dianthus Therapeutics, Inc. DNTH | BCLS Fund III Investments, LP | 2,482,250 7.500% | -207,457![]() (-7.71%) | Filing History |
| 2025-08-14 3:47 pm Purchase | 2025-06-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Vestal Point Capital, LP | 3,200,000 9.950% | 1,499,931![]() (+88.23%) | Filing History |
| 2025-05-15 4:55 pm Unchanged | 2025-03-31 | 13G | Dianthus Therapeutics, Inc. DNTH | RA CAPITAL MANAGEMENT L.P. | 2,866,733 8.900% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:34 pm Unchanged | 2025-03-31 | 13G | Dianthus Therapeutics, Inc. DNTH | TCG Crossover GP II, LLC | 1,501,624 4.700% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:14 pm Purchase | 2025-03-31 | 13G | Dianthus Therapeutics, Inc. DNTH | Vestal Point Capital, LP | 1,700,069 5.300% | 1,700,069![]() (New Position) | Filing History |
| 2025-05-12 10:28 am Purchase | 2025-03-31 | 13G | Dianthus Therapeutics, Inc. DNTH | FMR LLC | 4,482,609 14.000% | 2,264,397![]() (+102.08%) | Filing History |
| 2025-04-24 2:17 pm Sale | 2025-03-31 | 13G | Dianthus Therapeutics, Inc. DNTH | BlackRock Inc. BLK | 1,600,153 5.000% | -44,666![]() (-2.72%) | Filing History |

